These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 6306678

  • 21. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI, Hallenbeck JM, Brown CQ.
    Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967
    [Abstract] [Full Text] [Related]

  • 22. Naloxone: a study of its use in shock.
    Halpern J.
    J Emerg Nurs; 1984 Oct; 10(4):222-5. PubMed ID: 6381847
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Thyrotrophin-releasing hormone. New applications in the clinic.
    Griffiths EC.
    Nature; 1984 Oct; 322(6076):212-3. PubMed ID: 3090448
    [No Abstract] [Full Text] [Related]

  • 25. Beneficial effects of erythropoietin in preclinical models of shock and organ failure.
    Thiemermann C.
    Crit Care; 2007 Oct; 11(3):132. PubMed ID: 17543134
    [Abstract] [Full Text] [Related]

  • 26. Opioids and neuropeptides: mechanisms in circulatory shock.
    Bernton EW, Long JB, Holaday JW.
    Fed Proc; 1985 Feb; 44(2):290-9. PubMed ID: 3917942
    [Abstract] [Full Text] [Related]

  • 27. Endorphins in circulatory shock.
    Napolitano L, Chernow B.
    Crit Care Med; 1988 May; 16(5):566-7. PubMed ID: 3359796
    [No Abstract] [Full Text] [Related]

  • 28. Spinal shock and injury: experimental therapeutic approaches.
    Holaday JW, Faden AI.
    Adv Shock Res; 1983 May; 10():95-8. PubMed ID: 6880963
    [No Abstract] [Full Text] [Related]

  • 29. [Endorphins, enkephalins and their antagonists in clinical practice (review of the literature)].
    Oleĭnik VA, Khalangot ND.
    Vrach Delo; 1985 May; (5):80-6. PubMed ID: 2990108
    [No Abstract] [Full Text] [Related]

  • 30. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.
    Faden AI, Holaday JW.
    J Pharmacol Exp Ther; 1980 Mar; 212(3):441-7. PubMed ID: 7359345
    [Abstract] [Full Text] [Related]

  • 31. Medical treatment of acute spinal cord injuries.
    Ceylan S, Kalelioğlu M, Aktürk G, Aktürk F, Ceylan S.
    Res Exp Med (Berl); 1990 Mar; 190(2):111-9. PubMed ID: 2112263
    [Abstract] [Full Text] [Related]

  • 32. Cardiovascular consequences of endogenous opiate antagonism.
    Holaday JW.
    Biochem Pharmacol; 1983 Feb 15; 32(4):573-85. PubMed ID: 6299300
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Endorphins in traumatic spinal injury. Pathophysiologic studies and clinical implications.
    Faden AI, Holaday JW.
    Mod Probl Pharmacopsychiatry; 1981 Feb 15; 17():158-74. PubMed ID: 6276721
    [No Abstract] [Full Text] [Related]

  • 35. Thyrotropin-releasing hormone for spinal trauma.
    Hall ED, Braughler JM.
    N Engl J Med; 1982 Feb 18; 306(7):429-30. PubMed ID: 6799827
    [No Abstract] [Full Text] [Related]

  • 36. [Naloxone and endotoxic shock: a wonder drug?].
    Valdivielso A, Casado Flores J, Ruiz Beltrán A, García Pérez J, García-Onieva M, Hidalgo I.
    An Esp Pediatr; 1984 Feb 15; 20(2):85-90. PubMed ID: 6712029
    [Abstract] [Full Text] [Related]

  • 37. [Therapeutic effect of naloxone and its mechanisms in circulation shock].
    He F, Zheng MQ.
    Sheng Li Ke Xue Jin Zhan; 1989 Apr 15; 20(2):137-43. PubMed ID: 2555915
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of experimental spinal cord injury with TRH, naloxone, and dexamethasone.
    Arias MJ.
    Surg Neurol; 1987 Nov 15; 28(5):335-8. PubMed ID: 3116691
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.